![]() |
REGULATORY MEMORANDUM |
EPA Releases Final TSCA Section 6(h) Rules for Five PBT ChemicalsThe U.S. Environmental Protection Agency (EPA) released on December 22, 2020, final rules under Section 6(h) of the Toxic Substances Control Act (TSCA) for five persistent, bioaccumulative and toxic (PBT) chemicals -- decabromodiphenyl ether (decaBDE); phenol, isopropylated phosphate (3:1) (PIP (3:1)); 2,4,6-tris(tert-butyl)phenol (2,4,6-TTBP); hexachlorobutadiene (HCBD); and pentachlorothiophenol (PCTP). TSCA required EPA to take expedited action on specific PBT chemicals to address risk and reduce exposures to the extent practicable. EPA identified these five PBT chemicals for expedited action, following criteria outlined in TSCA. The final rules limit or prohibit the manufacture (including import), processing, and/or distribution in commerce for the following:
The final rules will be effective 30 days after publication in the Federal Register. In a related action, EPA announced on December 8, 2020, the receipt of a manufacturer-requested risk evaluation for two other PBT chemicals within the octahydro-tetramethyl-naphthalenyl-ethanone (OTNE) chemical category. EPA states that it will soon open a public comment period on the request and, if granted, these chemicals would be subject to the full TSCA risk evaluation process. More information on the manufacturer request is available in our December 9, 2020, blog item, “EPA Receives Manufacturer Request for Risk Evaluation of Chemical Category under TSCA Section 6.” EPA’s website includes a summary of the uses, identified hazards, and risk management actions for each of the five PBT chemicals. The following summary includes minor revisions and clarifications to the information provided by EPA. Stakeholders should check the final rules to confirm the requirements. DecaBDE EPA is prohibiting the manufacture (including import), processing, and distribution in commerce of decaBDE, and products containing decaBDE, for all uses, except for the following:
PIP (3:1) EPA is prohibiting processing and distribution in commerce of PIP (3:1), and products containing the chemical substance, for all uses, except for the following:
EPA states that it is requiring that persons manufacturing, processing, and distributing in commerce PIP (3:1) and products containing PIP (3:1) notify their customers of these restrictions. EPA is also prohibiting releases to water from the remaining manufacturing, processing, and distribution in commerce activities and requiring commercial users of PIP (3:1) and PIP (3:1)-containing products to follow existing regulations and best practices to prevent releases to water during use. 2,4,6-TTBP EPA is prohibiting the distribution in commerce of 2,4,6-TTBP and products containing 2,4,6-TTBP at concentrations above 0.3% by weight in any container with a volume of less than 35 gallons to prevent effectively the use of 2,4,6-TTBP as a fuel additive or fuel injector cleaner by consumers and small commercial operations (e.g., automotive repair shops, marinas). EPA is also prohibiting the processing and distribution in commerce of 2,4,6-TTBP, and products containing 2,4,6-TTBP, for use as an oil or lubricant additive in concentrations above 0.3% by weight regardless of container size. HCBD EPA is prohibiting the manufacturing (including import), processing, and distribution in commerce of HCBD and HCBD-containing products or articles, except for the unintentional production of HCBD as a byproduct during the production of chlorinated solvents, and the processing and distribution in commerce of HCBD for burning as a waste fuel. PCTP EPA is prohibiting the manufacture (including import), processing, and distribution in commerce of PCTP, and products or articles containing PCTP, unless PCTP concentrations are at or below 1% by weight. Commentary To our eye, EPA’s actions are neither surprising nor inappropriate. We will continue to evaluate the rules as EPA’s many actions over the past several weeks warrant close scrutiny. |
BERGESON & CAMPBELL, P.C. 2200 Pennsylvania Ave, N.W. Suite 100W | Washington, D.C. 20037 | (202) 557-3800 • (202) 557-3836 (fax) | www.lawbc.com © 2023 Bergeson & Campbell, P.C. All Rights Reserved |